BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 34824200)

  • 1. Signaling pathways and intervention therapies in sepsis.
    Zhang YY; Ning BT
    Signal Transduct Target Ther; 2021 Nov; 6(1):407. PubMed ID: 34824200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.
    Chen F; Zou L; Williams B; Chao W
    Antioxid Redox Signal; 2021 Nov; 35(15):1324-1339. PubMed ID: 33588628
    [No Abstract]   [Full Text] [Related]  

  • 4. The cellular basis of organ failure in sepsis-signaling during damage and repair processes.
    Bauer M; Wetzker R
    Med Klin Intensivmed Notfmed; 2020 May; 115(Suppl 1):4-9. PubMed ID: 32236799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapeutic targets for sepsis.
    Tindal EW; Armstead BE; Monaghan SF; Heffernan DS; Ayala A
    Expert Opin Ther Targets; 2021 Mar; 25(3):175-189. PubMed ID: 33641552
    [No Abstract]   [Full Text] [Related]  

  • 6. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment.
    Assimakopoulos SF; Triantos C; Thomopoulos K; Fligou F; Maroulis I; Marangos M; Gogos CA
    Infection; 2018 Dec; 46(6):751-760. PubMed ID: 30003491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential Extracorporeal Therapy in Sepsis.
    De Rosa S; Cutuli SL; Lorenzin A; Zanella M
    Contrib Nephrol; 2023; 200():149-159. PubMed ID: 37290408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Inflammatory Complex in Sepsis: Septic Cachexia as a Novel Potential Therapeutic Target.
    Kaneki M
    Shock; 2017 Dec; 48(6):600-609. PubMed ID: 28520694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
    Hattori Y; Hattori K; Suzuki T; Matsuda N
    Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses.
    Matsuda A; Jacob A; Wu R; Aziz M; Yang WL; Matsutani T; Suzuki H; Furukawa K; Uchida E; Wang P
    J Nippon Med Sch; 2012; 79(1):4-18. PubMed ID: 22398786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?].
    Karima R
    Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis.
    Sharma A; Kontodimas K; Bosmann M
    Antioxid Redox Signal; 2021 Dec; 35(16):1376-1392. PubMed ID: 34348482
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathogenesis of sepsis.
    Stearns-Kurosawa DJ; Osuchowski MF; Valentine C; Kurosawa S; Remick DG
    Annu Rev Pathol; 2011; 6():19-48. PubMed ID: 20887193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunopathology of sepsis and potential therapeutic targets.
    van der Poll T; van de Veerdonk FL; Scicluna BP; Netea MG
    Nat Rev Immunol; 2017 Jul; 17(7):407-420. PubMed ID: 28436424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of neutrophil-endothelial cell interactions in sepsis: new synergistic approaches employing organ-on-chip, omics, immune cell phenotyping and
    Liu D; Langston JC; Prabhakarpandian B; Kiani MF; Kilpatrick LE
    Front Cell Infect Microbiol; 2023; 13():1274842. PubMed ID: 38259971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis: from bench to bedside.
    Silva E; Passos Rda H; Ferri MB; de Figueiredo LF
    Clinics (Sao Paulo); 2008 Feb; 63(1):109-20. PubMed ID: 18297215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.
    Molano Franco D; Arevalo-Rodriguez I; Roqué I Figuls M; Montero Oleas NG; Nuvials X; Zamora J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011811. PubMed ID: 31038735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 and Its Beneficial Role in Sepsis-Induced T Lymphocyte Dysfunction.
    de Roquetaillade C; Monneret G; Gossez M; Venet F
    Crit Rev Immunol; 2018; 38(6):433-451. PubMed ID: 31002599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis.
    Leite-Avalca MCG; Zampronio A; Lehmann C
    Shock; 2021 Nov; 56(5):673-681. PubMed ID: 33625115
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.